tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VCYT Stock Latest News

Veracyte Shareholders Approve Directors and 2023 Plan Amendment
Company AnnouncementsVeracyte Shareholders Approve Directors and 2023 Plan Amendment
1M ago
8K
VCYT
Veracyte says new findings suggest potential of novel molecular signatures
PremiumThe Fly
Veracyte says new findings suggest potential of novel molecular signatures
2M ago
VCYT
Veracyte price target lowered to $27 from $33 at Needham
PremiumThe Fly
Veracyte price target lowered to $27 from $33 at Needham
3M ago
VCYT
Veracyte raises FY24 revenue view to $402M-$410M from $394M-$402M
PremiumThe Fly
Veracyte raises FY24 revenue view to $402M-$410M from $394M-$402M
3M ago
VCYT
Veracyte reports Q1 EPS (2c), consensus (17c)
PremiumThe Fly
Veracyte reports Q1 EPS (2c), consensus (17c)
3M ago
VCYT
Veracyte study shows Decipher Prostate Test is prognostic
PremiumThe FlyVeracyte study shows Decipher Prostate Test is prognostic
3M ago
VCYT
Veracyte files automatic mixed securities shelf
PremiumThe Fly
Veracyte files automatic mixed securities shelf
5M ago
VCYT
Cathie Wood’s ARK Investment bought 154K shares of Veracyte today
PremiumThe Fly
Cathie Wood’s ARK Investment bought 154K shares of Veracyte today
5M ago
VCYT
Veracyte price target raised to $33 from $30 at Needham
PremiumThe Fly
Veracyte price target raised to $33 from $30 at Needham
5M ago
VCYT
Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M
PremiumThe Fly
Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M
5M ago
VCYT
Veracyte reports Q4 GAAP EPS (39c) vs. (5c) last year
PremiumThe Fly
Veracyte reports Q4 GAAP EPS (39c) vs. (5c) last year
5M ago
VCYT
Veracyte Inc (VCYT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Veracyte Inc (VCYT) Q4 Earnings Cheat Sheet
5M ago
VCYT
Veracyte Streamlines Finance with Equity Sales Exemption
PremiumCompany AnnouncementsVeracyte Streamlines Finance with Equity Sales Exemption
6M ago
8K
VCYT
Veracyte Finalizes C2i Genomics Acquisition Deal
PremiumCompany Announcements
Veracyte Finalizes C2i Genomics Acquisition Deal
6M ago
8K
VCYT
Veracyte to acquire C2i Genomics for $70M upfront
PremiumThe Fly
Veracyte to acquire C2i Genomics for $70M upfront
7M ago
VCYT
Veracyte sees FY24 revenue $394M-$402M, consensus $391.5M
PremiumThe Fly
Veracyte sees FY24 revenue $394M-$402M, consensus $391.5M
7M ago
VCYT
Veracyte sees FY23 revenue $358M-$359M, consensus $352.78M
PremiumThe Fly
Veracyte sees FY23 revenue $358M-$359M, consensus $352.78M
7M ago
VCYT
Veracyte sees Q4 revenue $95M-$96M, consensus $89.91M
PremiumThe Fly
Veracyte sees Q4 revenue $95M-$96M, consensus $89.91M
7M ago
VCYT
Veracyte price target lowered to $30 from $35 at Needham
PremiumThe Fly
Veracyte price target lowered to $30 from $35 at Needham
9M ago
VCYT
Veracyte raises FY23 revenue view to $352M-$354M from $342M-$350M
PremiumThe FlyVeracyte raises FY23 revenue view to $352M-$354M from $342M-$350M
9M ago
VCYT
Veracyte reports Q3 EPS (41c), consensus (15c)
PremiumThe Fly
Veracyte reports Q3 EPS (41c), consensus (15c)
9M ago
VCYT
Veracyte enters In Vitro diagnostic agreement with Illumina
PremiumThe Fly
Veracyte enters In Vitro diagnostic agreement with Illumina
9M ago
VCYT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >